This inhibition results in increased p53 expression, activation of the p53 pathway, and reduced survival of HCT116 colon cancer cells via apoptosis induction and G2/M phase arrest (Zhang et al., 2022[267]). Here, TP53 is linked to malignant colon neoplasm.